Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hubert Pehamberger

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
The Journal of Investigative Dermatology|October 31, 2002
Selection of mimotopes of the cell surface adhesion molecule Mel-CAM from a random pVIII-28aa phage peptide libraryChristine Hafner, Ursula Samwald, Stefan Wagner, et al.
The Journal of Investigative Dermatology|June 16, 2005
The non-receptor-associated tyrosine kinase Syk is a regulator of metastatic behavior in human melanoma cellsChristoph Hoeller, Christiane Thallinger, Barbara Pratscher, et al.
The Journal of Investigative Dermatology|September 7, 2012
Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesisAndreas Bracher, Ana Soler Cardona, Stefanie Tauber, et al.
The Journal of Investigative Dermatology|May 13, 2006
The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanomaIchiro Okamoto, Florian Roka, Julia Krögler, et al.
The Journal of Investigative Dermatology|June 16, 2005
Clusterin regulates drug-resistance in melanoma cellsChristoph Hoeller, Barbara Pratscher, Christiane Thallinger, et al.
International Journal of Cancer|November 6, 2003
Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neuJoanna Jasinska, Stefan Wagner, Christian Radauer, et al.
Plos One|October 11, 2012
Proteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interactionVerena Paulitschke, Silke Gruber, Elisabeth Hofstätter, et al.
American Journal of Therapeutics|November 2, 2013
Who benefits most from adjuvant interferon treatment for melanoma?Helen Gogas, Huseyin Abali, Paolo A Ascierto, et al.
Journal of Cutaneous Pathology|January 20, 2006
Expression of stromal cell markers in distinct compartments of human skin cancersMargit A Huber, Norbert Kraut, Norbert Schweifer, et al.
The Journal of Investigative Dermatology|June 6, 2003
Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation modelChristiane Thallinger, Markus F Wolschek, Volker Wacheck, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
The Journal of Investigative Dermatology|October 31, 2002
Selection of mimotopes of the cell surface adhesion molecule Mel-CAM from a random pVIII-28aa phage peptide libraryChristine Hafner, Ursula Samwald, Stefan Wagner, et al.
The Journal of Investigative Dermatology|June 16, 2005
The non-receptor-associated tyrosine kinase Syk is a regulator of metastatic behavior in human melanoma cellsChristoph Hoeller, Christiane Thallinger, Barbara Pratscher, et al.
The Journal of Investigative Dermatology|September 7, 2012
Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesisAndreas Bracher, Ana Soler Cardona, Stefanie Tauber, et al.
The Journal of Investigative Dermatology|May 13, 2006
The EGF A61G polymorphism is associated with disease-free period and survival in malignant melanomaIchiro Okamoto, Florian Roka, Julia Krögler, et al.
The Journal of Investigative Dermatology|June 16, 2005
Clusterin regulates drug-resistance in melanoma cellsChristoph Hoeller, Barbara Pratscher, Christiane Thallinger, et al.
International Journal of Cancer|November 6, 2003
Inhibition of tumor cell growth by antibodies induced after vaccination with peptides derived from the extracellular domain of Her-2/neuJoanna Jasinska, Stefan Wagner, Christian Radauer, et al.
Plos One|October 11, 2012
Proteome analysis identified the PPARγ ligand 15d-PGJ2 as a novel drug inhibiting melanoma progression and interfering with tumor-stroma interactionVerena Paulitschke, Silke Gruber, Elisabeth Hofstätter, et al.
American Journal of Therapeutics|November 2, 2013
Who benefits most from adjuvant interferon treatment for melanoma?Helen Gogas, Huseyin Abali, Paolo A Ascierto, et al.
Journal of Cutaneous Pathology|January 20, 2006
Expression of stromal cell markers in distinct compartments of human skin cancersMargit A Huber, Norbert Kraut, Norbert Schweifer, et al.
The Journal of Investigative Dermatology|June 6, 2003
Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation modelChristiane Thallinger, Markus F Wolschek, Volker Wacheck, et al.
Pageof 12